GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: In SBS patients, available biomarkers assisting the interpretation of intestinal adaptation and response to GLP-2 analog treatment are extremely rare, prompting our current comprehensive comparison of potential markers.